CPH creso pharma limited

News: CPH Creso Pharma Says Half Year Revenue Rose 109 Percent To A$ 3.032 Million

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 31 (Reuters) - Creso Pharma Ltd (CPH) :

    • HALF YEAR REVENUE ROSE 109 PERCENT TO A$ 3.032 MILLION
    • HY NET LOSS ATTRIBUTABLE A$19.0 MILLION VERSUS A$17.4 MILLION

    CPH)

    (([email protected];))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.